FDA Approves Moderna’s COVID-19 Vaccine for Some Children

The approval is for a vaccine that was previously available through emergency authorization.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Federal regulators have approved a COVID-19 vaccine made by Moderna for some children aged 6 months through 11 years, according to an approval letter made public on July 10.

The Food and Drug Administration approved Spikevax, the vaccine, for children at least 6 months of age who are pegged as being at heightened risk for COVID-19, the FDA’s top vaccine official, Dr. Vinay Prasad, told Moderna in the missive.